StockData
MetaVia Inc. logo

MetaVia Inc. (MTVA) stock

MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.06−0.19 (-15.20%)

Close on Nov 18, 2026Market cap $6.98MP/E –Yield –

MetaVia net income

Net income is the profit left for shareholders after every expense, interest and tax.

MetaVia's net income for the twelve months ending Jun 30, 2026 was -$14.45M. For fiscal 2025 it was -$12.97M. The highest annual figure on record is -$320.00K in fiscal 2014.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.97M–
FY2024Dec 31, 2024-$27.59M–
FY2023Dec 31, 2023-$12.47M–
FY2022Dec 31, 2022-$13.97M–
FY2021Dec 31, 2021-$15.28M–
FY2020Dec 31, 2020-$29.68M–
FY2019Dec 31, 2019-$21.31M–
FY2018Dec 31, 2018-$15.53M–
FY2017Dec 31, 2017-$33.42M–
FY2016Dec 31, 2016-$14.59M–
FY2015Dec 31, 2015-$9.03M–
FY2014Dec 31, 2014-$320.00K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.32M–
Q1 FY2026Mar 31, 2026-$3.82M–
Q4 FY2025Dec 31, 2025-$1.93M–
Q3 FY2025Sep 30, 2025-$3.38M–
Q2 FY2025Jun 30, 2025-$4.00M–
Q1 FY2025Mar 31, 2025-$3.67M–
Q4 FY2024Dec 31, 2024-$5.17M–
Q3 FY2024Sep 30, 2024-$5.65M–
Q2 FY2024Jun 30, 2024-$10.05M–
Q1 FY2024Mar 31, 2024-$6.71M–
Q4 FY2023Dec 31, 2023-$5.31M–
Q3 FY2023Sep 30, 2023-$3.82M–
Q2 FY2023Jun 30, 2023-$734.00K–
Q1 FY2023Mar 31, 2023-$2.60M–
Q4 FY2022Dec 31, 2022-$4.68M–
Q3 FY2022Sep 30, 2022-$3.11M–
Q2 FY2022Jun 30, 2022-$3.30M–
Q1 FY2022Mar 31, 2022-$2.88M–
Q4 FY2021Dec 31, 2021-$4.58M–
Q3 FY2021Sep 30, 2021-$3.46M–
Q2 FY2021Jun 30, 2021-$3.92M–
Q1 FY2021Mar 31, 2021-$3.32M–
Q4 FY2020Dec 31, 2020-$19.51M–
Q3 FY2020Sep 30, 2020-$3.05M–
Q2 FY2020Jun 30, 2020-$2.38M–
Q1 FY2020Mar 31, 2020-$4.73M–
Q4 FY2019Dec 31, 2019-$13.33M–
Q3 FY2019Sep 30, 2019-$3.62M–
Q2 FY2019Jun 30, 2019-$1.90M–
Q1 FY2019Mar 31, 2019-$2.46M–
Q4 FY2018Dec 31, 2018-$3.66M–
Q3 FY2018Sep 30, 2018-$6.08M–
Q2 FY2018Jun 30, 2018-$6.68M–
Q1 FY2018Mar 31, 2018-$7.22M–
Q4 FY2017Dec 31, 2017-$6.75M–
Q3 FY2017Sep 30, 2017-$8.67M–
Q2 FY2017Jun 30, 2017-$10.50M–
Q1 FY2017Mar 31, 2017-$7.50M–
Q4 FY2016Dec 31, 2016-$7.21M–
Q3 FY2016Sep 30, 2016-$3.88M–

More MetaVia figures

See a number that looks wrong?